Center for Business Models in Healthcare
Contact Us | Privacy | Legal | Home
About the CenterOur WorkPublicationsResearch ProgramsAbout Executive Frameworks

SELECT PUBLICATIONS

Trosman JR, Weldon CB, Kelley RK, Phillips KA. Barriers to insurance coverage of next-generation tumor sequencing by U.S. payers. J Clin Oncol, 2014 (suppl; abstr 6545)

Murphy AM, Weldon CB, Trosman JR, Dupuy D, Schink JC, Ansell D, Simon MA. Does insurance mix impact utilization of published care practices and guidelines among breast imaging sites? J Clin Oncol, 2014 (suppl; abstr e17560)

Weldon CB, Trosman JR, Simon MA, Dupuy D, Roggenkamp B, Gradishar WJ, Murphy AM. Do breast cancer treatment and imaging providers follow hereditary breast and ovarian cancer risk screening guidelines? J Clin Oncol, 2014 (suppl; abstr e17626)

Abramowitz A, Trosman JR, Weldon CB, Schink JC, Simon MA. How are young women 18-24 counseled on hereditary breast and ovarian cancer (HBOC) testing? J Clin Oncol, 2014 (suppl; abstr 1546)

Weldon CB, Trosman JR, Roggenkamp B, Dupuy D, Gradishar WJ, Simon MA, Murphy AM. Do hospitals in a large metropolitan area utilize published breast cancer care practices and guidelines? J Clin Oncol, 2014 (suppl; abstr 1093)

Phillips KA, Sakowski JA, Trosman J, Douglas MP, Liang SY, Neumann P. The economic value of personalized medicine tests: what we know and what we need to know. Genet Med. 2013 Nov 14. doi: 10.1038/gim.2013. PMID: 24232413.

Trosman JT, Weldon CB. Models on Care Delivery. Chapter 17. Editors: Al Benson III, MD, A Chakravarthy, MD, Stanley Hamilton, MD. Cancers of the Colon and Rectum. A Multidisciplinary Approach to Diagnosis and Management Series. 288 pages Hardback. ISBN13 9781936287581

Rauscher GH, Murphy AM, Orsi JM, Dupuy DM, Grabler PM, Weldon CB. Beyond the mammography quality standards act: measuring the quality of breast cancer screening programs. AJR Am J Roentgenol. 2014 Jan; 202(1):145-51.

Trosman JR, Weldon CB, Schink JC, Gradishar WJ, and Benson AB. What do providers, payers and patients need from comparative effectiveness research on diagnostics? The case of HER2/Neu testing in breast cancer. Journal of Comparative Effectiveness Research, July 2013, Vol. 2, No. 4, Pages 461-477.

Schink JS, Trosman JR, Weldon CB, Siziopikou K, Gradishar WJ, Tsongalis GJ, Patel J, Benson AB, Perez E. Biomarker testing methods in breast, gastric and lung cancers - a benchmarking survey of NCI cancer centers. J Clin Oncol 31, 2013 (suppl; abstr e22093)

Weldon CB, Trosman JR, Benson AB, Tsongalis GJ, Siziopikou K, Gradishar WJ, Schink JS. Are oncologists involved in cancer biomarker decisions at their institutions? J Clin Oncol 31, 2013 (suppl; abstr 6617)

Siziopikou K, Weldon CB, Trosman JR, Gradishar WJ, Schink JS. What are NCI designated cancer centers using for breast cancer HER2 testing? J Clin Oncol 31, 2013 (suppl; abstr 626)

Weldon CB, Trosman JR, Schink JC. Cost of Cancer: There Is More to It Than Containing Chemotherapy Costs. Oncology. 2012, Vol. 26 No. 11

Weldon CB, Trosman JR, Gradishar WJ, Benson AB, Schink JC. Barriers to the Use of Personalized Medicine in Breast Cancer. Journal of Oncology Practice. 2012;8(4):24e-31e.

Weldon CB, Trosman JR, Dupuy DM, Roggenkamp B, Schink JC, Orsi JM, Murphy AM. Do patient tracking, follow-up, and referral practices contribute to breast cancer disparities in a large urban area? J Clin Oncol 30, 2012 (suppl; abstr 6120)

Dupuy DM, Orsi JM, Rauscher G, Murphy AM, Weldon CB, Trosman JR, Robinson PA, Marcus EA. Examining variation in mammography and breast cancer treatment quality. J Clin Oncol 30, 2012 (suppl; abstr e16531)

Trosman JR, Weldon CB, Dupuy DM, Roggenkamp B, Ganschow P, Schink JC, Murphy AM. Why do breast cancer programs fail to refer patients to genetic counseling upon obtaining family history? J Clin Oncol 30, 2012 (suppl; abstr 1553)

Weldon CB, Trosman JR, Dupuy DM, Roggenkamp B, Ganschow P, Schink JC, Murphy AM. Are breast cancer screening patients with family cancer history directed to genetic counseling/testing? Cancer Epidemiol Biomarkers Prev 2011;20(10 Suppl):A38.

Tsongalis GT, Weldon CB, Trosman JR, Gradishar WJ, Schink JC. Barriers to implementing primary HER2 FISH testing. J Clin Oncol 29: 2011 (suppl; abstr e16642)

Trosman JR, Weldon CB, Benson AB III, Gradishar WJ, Schink JC. "Oncology Medical Home" to address challenges in breast cancer care delivery. J Clin Oncol 29: 2011 (suppl; abstr e16641)

Doll KM, Weldon CB, Trosman JR, H Wetzel HH, Fallen TJ, Gradishar WJ, Schink JC. BRCA+ test result impact and timing on surgical treatment decisions for patients with breast cancer. J Clin Oncol 29: 2011 (suppl; abstr 626)

Schink JC, Doll KM, Weldon CB, Trosman JR, Wetzel HH, Fallen TJ, Gradishar WJ. Prophylactic oophorectomy for patients with breast cancer with BRCA results. J Clin Oncol 29: 2011 (suppl; abstr 1533)

Trosman JR, Van Bebber SL, Phillips KA. Health technology assessment and private payer's coverage of personalized medicine. Am J Manag Care. 2011;17 Suppl 5:SP53-60. PMID:21711078

Weldon CB, Trosman JR, Dupuy DM, Alvarez RD, Murphy AM. Breast Cancer Care Improvement in an Urban Environment. AcademyHealth 2011 Annual Research Meeting.

Trosman JR, Weldon CB, Tsongalis GJ, Phillips KA, A Standardized BCR-ABL Monitoring Test: Assessment of Potential Adoption Impacts In Healthcare In the United States. Blood 2010 116:4754.

Trosman JR, Van Bebber S.L., Phillips K.A.. Coverage Policy Development for Personalized Medicine: Private Payer Perspective on Developing Policy for the 21-Gene Assay. Journal of Oncology Practice. September 2010 2010;6(5): 238-242. PMID:21197187

Schink J, Weldon CB, Trosman JR, Benson A, Gradishar W. Features of an "Oncology Medical Home": Addressing Challenges in Cancer Care Delivery. Academy Health Annual Research Meeting, June 27-29, 2010, Boston, MA.

Van Bebber S, Trosman JR, Phillips K. One Size Does Not Fit All: Payers Use of Evidence Frameworks to Make Coverage and Policy Decisions. Academy Health Annual Research Meeting, June 27-29, 2010, Boston, MA.

Van Bebber SL, Trosman JR, Liang SY, Wang G, Marshall DA, Knight S & Phillips KA. Capacity building for assessing new technologies: approaches to examining personalized medicine in practice. Personalized Medicine (2010) 7(4), 427-439 PMID 21857867

Schink J, Weldon CB, Trosman JR, Benson A, Löffler A, Gradishar W. Care delivery barriers to personalized medicine in breast cancer. J Clin Oncol 28:15s, 2010 (suppl; abstr 6146)

Trosman JR, Weldon CB, Gradishar W, Schink J. Timing of genetic testing relative to breast cancer surgery. J Clin Oncol 28:15s, 2010 (suppl; abstr 666).





© Copyright 2006-2017 Executive Frameworks, Ltd. All rights reserved.